The use of liposomal anthracycline analogues for childhood malignancies: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of liposomal anthracycline analogues for childhood malignancies: A systematic review

Published:2011-09 Issue:13 Volume:47 Page:2000-2008
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sieswerda E.,Kremer L.C.M.,Caron H.N.,van Dalen E.C.

Funder

Foundation of Paediatric Cancer Research (SKK), The Netherlands

Stichting Kinderen Kankervrij (KiKa), The Netherlands

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. van Dalen EC, Raphael MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Syst Rev 2009;(1):CD006647.

2. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study;van Dalen;Eur J Cancer,2006

3. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review;Kremer;Ann Oncol,2002

4. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia;Lipshultz;J Clin Oncol,2005

5. van Dalen EC, Michiels EM, Caron HN, Kremer LC. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev 2006;(4):CD005006.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines;Children;2024-07-22

2. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century;Nature Reviews Clinical Oncology;2023-07-24

3. Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib;Anti-Cancer Agents in Medicinal Chemistry;2020-06-14

4. Therapeutic Opportunities in Neuroblastoma Using Nanotechnology;Journal of Pharmacology and Experimental Therapeutics;2019-01-11

5. Nanomedicines for Pediatric Cancers;ACS Nano;2018-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3